IDEAS home Printed from https://ideas.repec.org/p/ess/wpaper/id2640.html
   My bibliography  Save this paper

Bridging the Gap: Improving Clinical Development and the Regulatory Pathways for Health Products for Neglected Diseases

Author

Listed:
  • Thomas J. Bollyky

Abstract

There has been tremendous progress over the last decade in the development of health products for neglected diseases. These include drugs, vaccines, and diagnostics for malaria and tuberculosis, which kill millions of people annually, plus other diseases like changes and dengue fever, which may less familiar, but nonetheless exact a large and often lethal toll in the world’s poorest communities. Led by product development public- private partnerships (PDPs) and fueled by the support of the Bill & Melinda Gates Foundation, the National Institutes of Health, and other donors, there are now dozens of candidate products in the pipeline. [Working Paper No. 217]

Suggested Citation

  • Thomas J. Bollyky, 2010. "Bridging the Gap: Improving Clinical Development and the Regulatory Pathways for Health Products for Neglected Diseases," Working Papers id:2640, eSocialSciences.
    • Handle: RePEc:ess:wpaper:id:2640
    Note: Institutional Papers
    as

    Download full text from publisher

    File URL: http://www.esocialsciences.org/Download/repecDownload.aspx?fname=Document1872010360.9406855.pdf&fcategory=Articles&AId=2640&fref=repec
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Vincent Ahonkhai & Samuel F Martins & Alexandre Portet & Murray Lumpkin & Dan Hartman, 2016. "Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-12, November.
    2. Nerina Vischer & Constanze Pfeiffer & Manuela Limacher & Christian Burri, 2017. ""You can save time if…"—A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-19, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ess:wpaper:id:2640. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Padma Prakash (email available below). General contact details of provider: http://www.esocialsciences.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.